These findings could help guide the development of new treatments for psychiatric and neurological disorders.  

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

By giving providers greater insight into a tumor’s molecular footprint, the method could also reduce the need for invasive biopsies.

Researchers radiolabeled the drug so that they could follow its movement and breakdown in the body to help visualize areas of oxidative stress.

Experts hope the information gained from their research could help providers better determine whether patients will regain mobility after sustaining an injury. 

If 25% tariffs go into effect, it could have a big impact on the cost of medical imaging and radiotherapy systems, with many manufacturing facilities in Mexico. 

There are numerous radiotracers specifically designed to identify prostate cancer, but experts say one may be superior to the others at both the patient and lesion level. 

If approved, the two agents could offer providers greater insight into the process of patients’ neurodegeneration.